Trigeminal Neuralgia

Our Specialists for Trigeminal Neuralgia

Trigeminal neuralgia is a condition where the choice of surgeon and the choice of procedure matter as much as the diagnosis itself. UChicago is one of a small number of centers that offers every modern option for trigeminal neuralgia — microvascular decompression, Gamma Knife radiosurgery, and all three percutaneous rhizotomy techniques — under one roof, so your treatment fits your anatomy, your age, and your life.

Peter Christian Warnke, M.D.

Section Chief, Functional Neurosurgery & Epilepsy

Dr. Warnke is an international leader in functional neurosurgery and has performed over 6,000 stereotactic surgeries and more than 3,000 brain tumor surgeries. He is only the second neurosurgeon worldwide to perform laser hemispherotomy, and he has completed over 400 laser ablation surgeries since arriving at UChicago. He is funded by four NIH grants including the BRAIN Initiative, and he directs the NAUTILUS trial for thalamic stimulation in drug-resistant epilepsy. For trigeminal neuralgia, Dr. Warnke is one of the few surgeons in the Midwest who personally performs every modern option — microvascular decompression, Gamma Knife radiosurgery, and all three percutaneous rhizotomy techniques (balloon, glycerol, and radiofrequency) — drawing on more than 6,000 stereotactic procedures over his career. If you have trigeminal neuralgia at UChicago, he is likely to be part of the team deciding which procedure fits you.

Peleg Horowitz, M.D., Ph.D.

Co-Director, Pituitary & Neuroendocrine Disorders Program

Dr. Horowitz is a skull base and neuro-oncology surgeon who also serves as Director of Quality and Associate Program Director for the Neurological Surgery residency. His laboratory research has identified novel genes driving meningioma and pediatric glioma formation, with work published in Nature Genetics and PNAS, and is funded by the DoD Neurofibromatosis Research Program. He holds a PhD in neuroscience from Northwestern and completed residency at Brigham and Women's/Boston Children's with a skull base fellowship at MD Anderson. Dr. Horowitz is a skull base-trained neurosurgeon who performs microvascular decompression at UChicago, using the same microsurgical techniques he trained on at Brigham and Women's and MD Anderson for other posterior fossa and cerebellopontine angle procedures. For patients with classic trigeminal neuralgia and clear neurovascular compression on MRI, he is one of the surgeons who offers the open operation that has the best long-term cure rates.

David Satzer, M.D.

Functional Neurosurgery & Epilepsy

Dr. Satzer is a functional neurosurgeon specializing in epilepsy surgery, laser ablation, and deep brain stimulation. He is a recipient of the American Epilepsy Society Junior Investigator Award, and his research focuses on local field potentials and aperiodic neural activity as biomarkers for seizures and neuromodulation. His recent work has appeared in Brain Stimulation (2025). Dr. Satzer is a functional neurosurgeon who offers percutaneous rhizotomy and stereotactic radiosurgical options for trigeminal neuralgia, with a particular focus on patients who are not candidates for open surgery — including older patients, those on anticoagulation, and patients with trigeminal neuralgia secondary to multiple sclerosis.

What Is Trigeminal Neuralgia?

Trigeminal neuralgia is a disorder of the fifth cranial nerve (the trigeminal nerve), which carries sensation from your face, scalp, teeth, and jaw to the brain. In people with trigeminal neuralgia, something irritates the nerve at its root — most often a small artery or vein that loops against it where it exits the brainstem — and the nerve begins misfiring, sending sudden bursts of pain to the brain in response to ordinary touch.

The pain is unlike almost anything else in medicine. Patients describe it as an electric shock, stabbing, or lightning bolt in the cheek, jaw, gums, or forehead. Each jolt lasts a second or two but can repeat in volleys, and even a light breeze on the face, a sip of water, or the act of smiling can set it off. Between attacks, most patients feel completely normal — which is one of the things that makes the condition so disorienting.

Trigeminal neuralgia is relatively rare — it affects about 4 to 13 people per 100,000 each year, most often adults over 50, and slightly more women than men. It has been called the "suicide disease" in older medical literature because, untreated, the pain can be unbearable and patients have historically become desperate. That is no longer the reality. With modern medications and modern surgery, almost everyone with trigeminal neuralgia can have their pain controlled or eliminated — the key is getting to the right team.

What Does It Feel Like?

Classic trigeminal neuralgia has a very recognizable pattern. If the pain you are describing matches several of these features, it is worth being evaluated by a neurologist or facial-pain specialist.

The classic pattern

• Sudden, severe, one-sided facial pain — usually in the cheek, jaw, gum, or forehead, and almost never crossing the midline
• Described as electric shock, stabbing, shooting, or burning, lasting seconds at a time
• Triggered by everyday activities: brushing teeth, shaving, washing the face, chewing, talking, drinking cold water, a breeze on the cheek
• Comes in clusters or volleys — several shocks in quick succession — followed by pain-free intervals that can last minutes, hours, or weeks
• Often starts mildly and gets worse over months to years, with fewer and shorter pain-free remissions
• No weakness or loss of facial sensation between attacks — the face looks and feels normal

Which branch of the nerve is affected

The trigeminal nerve has three main branches, and trigeminal neuralgia can involve one or more of them:

• V1 (ophthalmic branch) — forehead, eyebrow, upper eyelid. Less commonly affected on its own.
• V2 (maxillary branch) — cheek, upper lip, upper teeth, side of the nose. The most commonly affected branch.
• V3 (mandibular branch) — lower jaw, lower teeth, lower lip, chin. Also commonly involved.

Warning signs that it might not be classic trigeminal neuralgia

Some features should prompt your team to look harder for another cause — such as a tumor, multiple sclerosis, or a different facial pain syndrome:

• Pain on both sides of the face (especially in a younger patient)
• Persistent numbness or loss of sensation on the face
• Other neurologic symptoms: double vision, weakness, hearing loss, unsteadiness
• Onset before age 40 — raises suspicion for multiple sclerosis
• A constant, burning, aching pain between attacks — may point to atypical trigeminal neuralgia (TN2) or a different diagnosis entirely

How Is It Diagnosed?

Trigeminal neuralgia is primarily a clinical diagnosis — meaning your doctor makes the diagnosis by listening carefully to your history and examining you. No blood test or scan is required to confirm it. But imaging is essential for two reasons: to rule out a secondary cause (like a tumor or multiple sclerosis plaque) and to look for neurovascular compression at the trigeminal nerve root, which tells your surgical team whether microvascular decompression is likely to work.

High-resolution MRI

The single most important test is a dedicated trigeminal nerve MRI on a 3 Tesla scanner, with thin-slice sequences specifically designed to show the tiny space where the trigeminal nerve meets the brainstem. The sequences usually include FIESTA or CISS (which show the cerebrospinal fluid around the nerve in bright detail), time-of-flight MR angiography (which lights up arteries), and contrast-enhanced images. A well-done MRI can show an artery or vein actually touching and indenting the nerve in the majority of patients with classic trigeminal neuralgia.

In a large prospective MRI study, severe neurovascular contact — where a vessel clearly deforms the nerve — was found on the painful side in about 53% of patients, compared to only 13% on the non-painful side (Brain, 2015). Mere contact without deformation is common even in healthy people and is not diagnostic on its own.

Ruling out secondary causes

Before committing to treatment, your team will want to be sure the pain is not caused by something else pressing on or damaging the nerve:

• Tumors near the trigeminal nerve — especially vestibular schwannomas, meningiomas, and epidermoid cysts in the cerebellopontine angle
• Multiple sclerosis — MS can cause trigeminal neuralgia by damaging the nerve inside the brainstem. This is suspected when patients are younger, have bilateral symptoms, or have other neurologic findings, and it is confirmed with MRI of the brain.
• Arteriovenous malformations and other vascular lesions

Dental evaluation

Because the pain so often radiates into the teeth and jaw, many trigeminal neuralgia patients see a dentist first — sometimes undergoing multiple root canals or tooth extractions before the correct diagnosis is made. If your dentist cannot find a dental cause for your facial pain, insist on a referral to a neurologist.

Types of Trigeminal Neuralgia

Not all facial pain that looks like trigeminal neuralgia is the same, and the subtype matters because it predicts which treatments will work. The most widely used modern framework comes from the International Classification of Headache Disorders and a 2016 consensus by Cruccu and colleagues (Neurology, 2016).

Classical trigeminal neuralgia (TN1)

Sometimes called typical trigeminal neuralgia, this is the most common form. Patients have purely paroxysmal pain — sudden shocks with completely normal sensation in between — and imaging or surgery confirms that a blood vessel is compressing the nerve at the root. About 75% of patients fall into this category. Classical TN responds best to microvascular decompression, because the compression is the problem that needs to be fixed.

Idiopathic trigeminal neuralgia

Same clinical picture as classical TN — paroxysmal shocks, normal exam between attacks — but no neurovascular compression is visible on MRI and no other cause is found. Roughly 10% of patients. These patients may still benefit from MVD if compression is found at surgery, but percutaneous procedures and Gamma Knife are often preferred first.

Secondary trigeminal neuralgia

About 15% of patients have trigeminal neuralgia caused by an identifiable underlying condition. The most common causes are:

• Multiple sclerosis — MS plaques in the brainstem can damage the trigeminal nerve nucleus. Trigeminal neuralgia is the first symptom of MS in a small subset of patients, and about 2–5% of people with MS develop it.
• Tumors — vestibular schwannomas, meningiomas, and epidermoid cysts at the cerebellopontine angle can press on the nerve and cause TN-like pain. Removing the tumor is usually the best treatment.
• Arteriovenous malformations and other rare vascular lesions

Atypical trigeminal neuralgia (TN2)

Also called trigeminal neuralgia with concomitant continuous pain. Patients have the classic electric-shock attacks, but also a constant burning, aching, or throbbing background pain in the same area between attacks. Response rates to every treatment — medication, MVD, radiosurgery, rhizotomy — are lower in TN2 than in classic TN1. It is important to make this distinction upfront so expectations are realistic. Some patients with TN2 benefit from MVD anyway; others are better served by a combination of strategies including neuromodulation and multidisciplinary pain management.

How Is It Treated?

Step 1: Medication

Almost every patient starts with medication, and for many, medication is enough — at least for a while. The drug of first choice, backed by the strongest evidence and recommended by both the American Academy of Neurology and the European Academy of Neurology, is carbamazepine (AAN-EFNS Guidelines, 2008; EAN Guidelines, 2019).

• Carbamazepine (Tegretol) — the gold-standard medication. It provides meaningful pain relief in roughly 70–80% of patients at the start of therapy. Side effects include drowsiness, dizziness, double vision, low sodium, and — rarely — serious skin reactions and blood count problems that require monitoring.
• Oxcarbazepine (Trileptal) — very similar in efficacy to carbamazepine but generally better tolerated, so many neurologists now start with it instead. Hyponatremia (low sodium) is still a concern and needs to be monitored.
• Second-line options — lamotrigine, baclofen, gabapentin, and pregabalin can be added when first-line drugs partially work or are poorly tolerated.

Unfortunately, medications become less effective over time in many patients. Roughly half of all trigeminal neuralgia patients will eventually need a procedure, either because the pain breaks through the drugs or because the side effects become intolerable. When that happens, it is time to see a functional or skull-base neurosurgeon.

Step 2: Microvascular decompression (MVD) — the gold standard

If you have classic trigeminal neuralgia, are medically fit for anesthesia, and have neurovascular compression on MRI, microvascular decompression is the procedure with the highest chance of durable, drug-free pain relief. It is also the only procedure that does not rely on damaging the trigeminal nerve — instead, it fixes the underlying problem.

Through a small opening behind the ear, the surgeon works under the microscope to expose the trigeminal nerve at the brainstem. The offending blood vessel — usually a loop of the superior cerebellar artery — is gently lifted off the nerve and cushioned away with a tiny piece of Teflon felt. The nerve itself is left completely intact. Most patients wake up with their pain gone.

MVD is a full craniotomy, requires general anesthesia, and involves two to three nights in the hospital. In experienced hands, the serious complication rate is low (under 1% for major problems like hearing loss, facial weakness, stroke, or cerebrospinal fluid leak), and the long-term results are the best of any procedure for trigeminal neuralgia (NEJM, 1996).

Step 3: Gamma Knife stereotactic radiosurgery

Gamma Knife radiosurgery delivers a single highly focused dose of radiation (typically 80–90 Gy) to the trigeminal nerve as it leaves the brainstem. There is no incision, no anesthesia other than a light sedative, and most patients go home the same day. The downside is that the pain relief is not immediate — it typically takes 4 to 8 weeks to kick in. Gamma Knife is an excellent option for older patients, those on blood thinners that cannot be stopped, patients who would not tolerate a craniotomy, and anyone who prefers the least invasive approach.

Step 4: Percutaneous rhizotomy

Percutaneous procedures reach the trigeminal nerve through the cheek, passing a thin needle through a natural opening in the skull called the foramen ovale — all under X-ray guidance with the patient asleep or sedated. Once the needle is in position at the trigeminal ganglion, the nerve fibers responsible for pain are selectively damaged in one of three ways:

• Balloon compression — a tiny balloon is inflated inside Meckel's cave for about a minute, mechanically compressing the nerve. Quick and effective, commonly used for multiple sclerosis-related TN.
• Glycerol rhizolysis — a small amount of glycerol is injected into the cerebrospinal fluid surrounding the trigeminal ganglion, chemically damaging the pain fibers.
• Radiofrequency thermocoagulation — a small electrode heats the nerve precisely at the level of the affected branch, allowing selective targeting of V1, V2, or V3.

Percutaneous procedures are fast (usually under an hour), do not require a full craniotomy, and provide immediate pain relief in 90% or more of patients (Neurosurgery, 2001). The main trade-off is a higher rate of facial numbness afterward, and pain recurrence rates are higher than MVD over the long run.

Which procedure fits which patient?

• Classic TN with clear neurovascular compression on MRI, good surgical candidate: microvascular decompression is usually first choice.
• Older patients, multiple medical problems, on blood thinners: Gamma Knife or percutaneous rhizotomy.
• Patients with multiple sclerosis: percutaneous rhizotomy (especially balloon compression) or Gamma Knife — MVD is less effective here because the problem is inside the brainstem, not outside it.
• Recurrence after a previous procedure: any of the above, depending on what was done before. Repeat MVD, repeat radiosurgery, and switching to a percutaneous technique are all reasonable.

What Are the Outcomes?

Trigeminal neuralgia is, in many ways, one of the most rewarding conditions in neurosurgery to treat: a majority of patients wake up from the operating room with their pain gone. The harder question is how long that relief lasts, and here the differences between procedures become important.

Microvascular decompression has the most durable results

The landmark long-term series from Barker and Jannetta of 1,185 patients showed that 70% of MVD patients were completely pain-free and off medication 10 years after surgery, with an additional 4% having occasional pain that did not require treatment — and after the first two years, the annual rate of new recurrence fell below 1% (NEJM, 1996). These numbers have been reproduced in many subsequent series. When MVD works, it tends to keep working.

Gamma Knife radiosurgery — gentler, slower, less durable

In the largest prospective series of 497 patients from Marseille, 92% achieved initial pain relief, 80% remained pain-free at 5 years, and 68% at 10 years by the broader definition — while the strictest definition (no pain, no medication) dropped to 65% at 5 years and 45% at 10 years (J Neurosurgery, 2016). Kondziolka's Pittsburgh series of 503 patients showed similar results, with pain recurrence in about 43% of initially relieved patients over long follow-up (J Neurosurgery, 2010).

Percutaneous rhizotomy — fast, effective, repeatable

In the classic Kanpolat series of 1,600 patients followed for up to 25 years, radiofrequency rhizotomy achieved acute pain relief in 98% of patients, with roughly 58% of single-procedure patients still pain-free at 5 years and 52% at 10 years — and when repeat procedures were included, more than 90% of patients remained pain-controlled over the long run (Neurosurgery, 2001). One of the advantages of percutaneous procedures is that they are easily repeated if the pain comes back.

What to expect after treatment

Most patients who undergo a successful procedure are able to reduce or stop their carbamazepine over the following weeks. Numbness of the face is common after percutaneous procedures and radiosurgery (about 20% with Gamma Knife; higher with rhizotomy), much less common after MVD. Serious complications — stroke, hearing loss, permanent facial weakness, cerebrospinal fluid leak — are rare at experienced centers and occur in well under 2% of MVD cases.

The bottom line

If you have classic trigeminal neuralgia and are a good surgical candidate, microvascular decompression offers the best chance of long-term, drug-free pain relief. If you are older, medically fragile, or strongly prefer a less invasive option, Gamma Knife radiosurgery and percutaneous rhizotomy both give excellent short- and medium-term relief and can be repeated if pain returns. The right choice is the one that fits your pain, your anatomy, and your life — and that is a conversation to have with a surgeon who performs all of them.

References